verified SJR 0,505 · Q3 • database Scopus / SJR & Web of Science indexed

United States · Informa Healthcare

workspace_premium Q3 — Medicine (miscellaneous) lock Subscription

Cancer Investigation

Cancer Investigation is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 96. It has an SJR impact factor of 0,505 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,505.

ISSN: 0735-7907

Publisher: Informa Healthcare

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,505 Q3

H-index 96

Acceptance rate pie_chart

26% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,505

H-index

Docs (year)

Docs 3y

266

Total refs

3282

Cites 3y

414

Citable 3y

244

Cites/Doc 2y

1.66

Ref/Doc

43.18

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Assessment of Proliferative Activity in Colorectal Carcinomas by Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)

What Is the "Best" Platinum: Cisplatin, Carboplatin, or Oxaliplatin?

Dendritic Cell Vaccines - Hopeful or Hopeless?

Defining Clinically Meaningful Outcomes in the Evaluation of New Treatments for Oral Mucositis: Oral Mucositis Patient Provider Advisory Board

Comparison of Conventional Dose and Double Dose Carboplatin in Patients Receiving Cyclophosphamide Plus Carboplatin for Advanced Ovarian Carcinoma: A North Central Cancer Treatment Group Study

Common Variable Immunodeficiency and Breast Cancer

Clues to the Etiology of Childhood Brain Cancer: N-Nitroso Compounds, Polyomaviruses, and Other Factors of Interest

Clinical Course and Pathologic Findings After Gliadel¬Æ and Radiotherapy for Newly Diagnosed Malignant Glioma: Implications for Patient Management

Cisplatin and Irinotecan (CPT-11) for Peritoneal Mesothelioma

Cell Density-Dependent Proliferative Effects of Transforming Growth Factor (TGF)-beta1, beta2, and beta3 in Human Chondrosarcoma Cells HCS-2/8 Are Associated with Changes in the Expression of TGF-beta Receptor Type I

Capecitabine: Fixed Daily Dose and Continuous (Noncyclic) Dosing Schedule

Cancer Pharmacogenomics: SNPs, Chips, and the Individual Patient

SHOW MORE ARTICLES

Breast Cancer Control and African American Women: A Review*

8-Cl-cAMP Affects Glioma Cell-Cycle Kinetics and Selectively Induces Apoptosis

Applications of Image Analysis to Anatomic Pathology: Realities and Promises

Alternating Doublets: Establishing the Optimal Multifractionated Dosing Schedule to Administer Docetaxel, Cisplatin, Gemcitabine, and Vinorelbine in Combination

Adjuvant Postoperative 5-Fluorouracil Chemotherapy Combined with Pelvic Radiation for Rectal Cancer: Results from an Asian Population

Acute Myeloid Leukemia in Children: A Review of Risk Factors and Recent Trials

Action of Troxacitabine on Cells Transduced with Human Cytidine Deaminase cDNA

A Preliminary Study of CA15-3, c-erbB-2, Epidermal Growth Factor Receptor, Cathepsin-D, and p53 in Saliva Among Women with Breast Carcinoma

A Phase II Study with CPT-11 Plus Leucovorin and Bolus IV 5-Fluorouracil in Patients with Advanced Colorectal Carcinoma

A Phase II Study of Weekly Alternating Chemotherapy in Extensive-Stage Small Cell Lung Cancer

A New Intensified Therapeutic Regimen for Advanced Head and Neck Squamous Cell Carcinomas: Where Does It Fit Among Available Treatment Options?

A Comparison of Survival Rates for Treatment of Melanoma Metastatic to the Brain

FAQs

Cancer Investigation has an SJR of 0,505 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Cancer Investigation is 26%.

Cancer Investigation

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Cancer Investigation?

What is the APC / publication cost?

What is the acceptance rate?